BioLineRx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioLineRx and other ETFs, options, and stocks.

About BLRX

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. 

CEO
Philip Adam Serlin
CEOPhilip Adam Serlin
Employees
24
Employees24
Headquarters
Modi'in, HaMerkaz
HeadquartersModi'in, HaMerkaz
Founded
2003
Founded2003
Employees
24
Employees24

BLRX Key Statistics

Market cap
15.02M
Market cap15.02M
Price-Earnings ratio
-1.63
Price-Earnings ratio-1.63
Dividend yield
Dividend yield
Average volume
205.04K
Average volume205.04K
High today
$3.40
High today$3.40
Low today
$3.28
Low today$3.28
Open price
$3.33
Open price$3.33
Volume
15.94K
Volume15.94K
52 Week high
$6.59
52 Week high$6.59
52 Week low
$2.15
52 Week low$2.15

BLRX News

Nasdaq 4d
BioLineRx Q1 2026 Earnings Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

BioLineRx Q1 2026 Earnings Transcript
Investing.com 6d
Earnings call transcript: BioLineRx’s Q1 2026 reveals mixed results - Investing.com

...

Earnings call transcript: BioLineRx’s Q1 2026 reveals mixed results - Investing.com
TipRanks 6d
BioLineRx Kicks Off GLIX1 Clinical Trial as Q1 2026 Loss Widens on Higher R&D Spend

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

More BLRX News

TipRanks 6d
BioLineRx reports Q1 EPS 0c vs. (0c) last year

Reports Q1 revenue $0.5M vs.$0.3M last year. “Since our last quarterly update, we achieved a significant milestone for our company and for the GLIX1 development...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.